Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Readmission | 7 | 2024 | 161 | 2.330 |
Why?
|
| Patient Discharge | 7 | 2022 | 150 | 2.260 |
Why?
|
| Retrospective Studies | 15 | 2023 | 2498 | 1.280 |
Why?
|
| Transitional Care | 2 | 2024 | 20 | 1.140 |
Why?
|
| Hospitals | 3 | 2022 | 79 | 0.950 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2022 | 552 | 0.920 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 351 | 0.910 |
Why?
|
| Telemedicine | 2 | 2024 | 187 | 0.840 |
Why?
|
| Dexamethasone | 1 | 2022 | 10 | 0.840 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 25 | 0.830 |
Why?
|
| Humans | 35 | 2024 | 18058 | 0.780 |
Why?
|
| Emergency Service, Hospital | 8 | 2023 | 357 | 0.760 |
Why?
|
| Medical Audit | 2 | 2020 | 40 | 0.750 |
Why?
|
| Outpatients | 2 | 2020 | 113 | 0.730 |
Why?
|
| Medical Records | 2 | 2020 | 108 | 0.720 |
Why?
|
| Self Report | 2 | 2022 | 252 | 0.690 |
Why?
|
| Disease Progression | 1 | 2020 | 255 | 0.680 |
Why?
|
| Aged | 18 | 2023 | 6258 | 0.640 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 163 | 0.630 |
Why?
|
| Male | 23 | 2023 | 10173 | 0.600 |
Why?
|
| Skilled Nursing Facilities | 1 | 2017 | 8 | 0.600 |
Why?
|
| Research Design | 1 | 2020 | 393 | 0.590 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 55 | 0.580 |
Why?
|
| Female | 26 | 2023 | 12838 | 0.580 |
Why?
|
| Acute Coronary Syndrome | 3 | 2021 | 17 | 0.560 |
Why?
|
| Patient Selection | 1 | 2017 | 194 | 0.550 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 1956 | 0.550 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 138 | 0.550 |
Why?
|
| Medicare | 1 | 2017 | 206 | 0.530 |
Why?
|
| Exercise | 1 | 2020 | 478 | 0.520 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 251 | 0.520 |
Why?
|
| Adult | 14 | 2023 | 7696 | 0.510 |
Why?
|
| Middle Aged | 18 | 2023 | 8073 | 0.490 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 257 | 0.470 |
Why?
|
| Sinusitis | 3 | 2017 | 14 | 0.440 |
Why?
|
| Electronic Health Records | 7 | 2020 | 734 | 0.430 |
Why?
|
| Pandemics | 3 | 2024 | 293 | 0.410 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 131 | 0.380 |
Why?
|
| Bariatric Surgery | 2 | 2023 | 128 | 0.370 |
Why?
|
| California | 10 | 2022 | 2327 | 0.350 |
Why?
|
| Risk Assessment | 5 | 2023 | 1137 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 205 | 0.330 |
Why?
|
| Guideline Adherence | 4 | 2017 | 160 | 0.310 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 1255 | 0.300 |
Why?
|
| Craniocerebral Trauma | 2 | 2017 | 10 | 0.300 |
Why?
|
| Troponin | 2 | 2023 | 9 | 0.280 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2016 | 23 | 0.280 |
Why?
|
| Breast Neoplasms | 3 | 2022 | 1023 | 0.260 |
Why?
|
| Chest Pain | 2 | 2023 | 14 | 0.240 |
Why?
|
| Stroke | 2 | 2016 | 306 | 0.230 |
Why?
|
| Sampling Studies | 2 | 2020 | 51 | 0.210 |
Why?
|
| Aftercare | 1 | 2022 | 49 | 0.210 |
Why?
|
| Mass Screening | 3 | 2022 | 678 | 0.200 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 330 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 324 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2023 | 2631 | 0.200 |
Why?
|
| Community Health Services | 1 | 2022 | 85 | 0.190 |
Why?
|
| United States | 4 | 2017 | 4119 | 0.190 |
Why?
|
| Troponin I | 1 | 2021 | 8 | 0.190 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 123 | 0.190 |
Why?
|
| Critical Pathways | 1 | 2021 | 11 | 0.190 |
Why?
|
| Dementia | 1 | 2023 | 103 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 119 | 0.190 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 35 | 0.190 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 121 | 0.190 |
Why?
|
| Patient Portals | 1 | 2021 | 25 | 0.190 |
Why?
|
| Heart Diseases | 1 | 2021 | 78 | 0.190 |
Why?
|
| Telephone | 1 | 2021 | 175 | 0.180 |
Why?
|
| Referral and Consultation | 1 | 2022 | 178 | 0.180 |
Why?
|
| Exercise Test | 1 | 2020 | 43 | 0.180 |
Why?
|
| Hospitals, Community | 2 | 2017 | 23 | 0.180 |
Why?
|
| Hospice and Palliative Care Nursing | 1 | 2019 | 6 | 0.180 |
Why?
|
| House Calls | 1 | 2019 | 13 | 0.180 |
Why?
|
| Home Care Services | 1 | 2019 | 23 | 0.170 |
Why?
|
| Regression Analysis | 1 | 2020 | 319 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 264 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 202 | 0.160 |
Why?
|
| Algorithms | 1 | 2020 | 235 | 0.160 |
Why?
|
| Registries | 2 | 2017 | 486 | 0.160 |
Why?
|
| Education, Continuing | 1 | 2017 | 3 | 0.160 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 6 | 0.150 |
Why?
|
| Heart Failure | 1 | 2023 | 391 | 0.150 |
Why?
|
| Income | 1 | 2017 | 95 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2019 | 253 | 0.150 |
Why?
|
| Survival Analysis | 1 | 2017 | 225 | 0.150 |
Why?
|
| Depression | 1 | 2022 | 512 | 0.150 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 445 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 233 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2021 | 692 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2023 | 1294 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 44 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 1346 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2015 | 24 | 0.130 |
Why?
|
| Prognosis | 1 | 2017 | 619 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 618 | 0.130 |
Why?
|
| Critical Care | 1 | 2016 | 72 | 0.130 |
Why?
|
| Accelerometry | 1 | 2015 | 37 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 43 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 144 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 31 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2014 | 54 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 643 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2016 | 164 | 0.120 |
Why?
|
| Walking | 1 | 2015 | 87 | 0.120 |
Why?
|
| Air Pollutants | 1 | 2014 | 48 | 0.120 |
Why?
|
| Air Pollution | 1 | 2014 | 40 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2015 | 270 | 0.120 |
Why?
|
| Internet | 1 | 2016 | 247 | 0.120 |
Why?
|
| Ambulatory Care | 1 | 2015 | 274 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 705 | 0.110 |
Why?
|
| Health Maintenance Organizations | 1 | 2015 | 481 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2016 | 462 | 0.110 |
Why?
|
| Primary Health Care | 2 | 2017 | 843 | 0.110 |
Why?
|
| Logistic Models | 3 | 2020 | 953 | 0.100 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 510 | 0.090 |
Why?
|
| Weight Loss | 2 | 2023 | 296 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2014 | 961 | 0.090 |
Why?
|
| Canada | 2 | 2017 | 66 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2017 | 53 | 0.070 |
Why?
|
| Acute Disease | 2 | 2017 | 138 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 26 | 0.070 |
Why?
|
| Mammography | 2 | 2015 | 173 | 0.060 |
Why?
|
| Sleep | 1 | 2022 | 56 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2022 | 53 | 0.050 |
Why?
|
| Child | 2 | 2022 | 2519 | 0.050 |
Why?
|
| Social Class | 1 | 2022 | 125 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2022 | 33 | 0.050 |
Why?
|
| Angina, Unstable | 1 | 2021 | 7 | 0.050 |
Why?
|
| Coronary Angiography | 1 | 2021 | 22 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 328 | 0.050 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2021 | 22 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 2021 | 26 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2023 | 248 | 0.050 |
Why?
|
| Government Programs | 1 | 2020 | 11 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 667 | 0.050 |
Why?
|
| Health Priorities | 1 | 2020 | 28 | 0.050 |
Why?
|
| Research Personnel | 1 | 2020 | 30 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 58 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2022 | 215 | 0.050 |
Why?
|
| Occult Blood | 1 | 2021 | 159 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2020 | 53 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 318 | 0.040 |
Why?
|
| Oregon | 1 | 2019 | 195 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1212 | 0.040 |
Why?
|
| Biomarkers | 1 | 2020 | 306 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2022 | 1259 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 634 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1428 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 384 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 2479 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 397 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 664 | 0.040 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 49 | 0.040 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2017 | 22 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 813 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2016 | 63 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 3714 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 8 | 0.030 |
Why?
|
| Mid-Atlantic Region | 1 | 2015 | 8 | 0.030 |
Why?
|
| Northwestern United States | 1 | 2015 | 47 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 48 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 394 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 3394 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Vehicle Emissions | 1 | 2014 | 21 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2016 | 136 | 0.030 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2016 | 248 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 257 | 0.030 |
Why?
|
| Survivors | 1 | 2015 | 157 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 350 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2014 | 108 | 0.030 |
Why?
|
| Health Promotion | 1 | 2016 | 295 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 205 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 1114 | 0.030 |
Why?
|
| Smoking | 1 | 2014 | 465 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 1484 | 0.020 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->